Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.
Volatility In Markets Increases Ahead Of Fed’s Rate Decision
US stocks closed lower on Friday, as investors digested recent economic data and awaited interest-rate decision from the Federal Reserve this week.
US producer prices increased slightly higher than expected during the month of November amid an increase in services costs.
